July 4, 2019 Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol
July 2, 2019 C-Path Taps Medical Science Operations Executive Kristen Swingle as Chief Operating Officer TUCSON, Ariz., July 2, 2019 — The Critical Path Institute (C-Path) is pleased to announce that after an extensive
June 25, 2019 Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials
June 19, 2019 The Critical Path for Parkinson’s consortium announces C-Path’s Data Sharing Pioneer Award recipients The Critical Path for Parkinson’s consortium (CPP) is pleased to announce the following recipients as the first to receive C
June 11, 2019 Scientific and Regulatory Considerations for the Analytical Validation of Assays Used in the Qualification of Biomarkers in Biological Matrices
June 11, 2019 C-Path’s PSTC Releases Points to Consider Outlining Recommendations for Analytical Validation of Assays Used in Qualifying Biomarkers The document serves as a guide to the analysis of biomarkers in drug development TUCSON, Ariz., June 11, 2019 — The Critical Pat
June 3, 2019 Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan
May 22, 2019 Measurement Comparability of Electronic and Paper Administered Visual Analogue Scales: A Review of Published Studies
May 16, 2019 Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials (May 16, 2019) This webinar provides an overview of the issues related to the use of paper backups in studies for which PRO data is collected ele
May 12, 2019 Parkinson’s Progression Markers Initiative (PPMI). Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson’s Disease
